From scissors to editors: how the evolution of precision is redefining therapeutic genome editing
Molecular Genetics and Genomics · 2026
DOI: 10.1007/s00438-026-02467-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Genetics and Genomics, 2026. Verfasst von Mohadese Rahbari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of cell and molecular biology-Genetics, University of science and culture, ACECR, Tehran, Iran. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Genetic Therapy, Precision Medicine. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Since its introduction as a genome-editing tool, CRISPR-based technology has undergone rapid refinement, with precision emerging as a central focus of development. Early CRISPR-Cas9 systems demonstrated unprecedented ease and efficiency in targeting specific DNA sequences, but concerns over off-target effects and variable editing outcomes limited their broader application. This review outlines the progression of CRISPR from its discovery in prokaryotes to its application as a versatile tool in precision medicine, where it supports targeted therapies for genetic disorders in various ways. Although technical challenges, including off-target editing and delivery inefficiencies, persist alongside ethical considerations of accessibility and long-term consequences, CRISPR's ongoing refinements and innovations reflect a clear trajectory toward greater specificity, safety, and predictability, positioning CRISPR as an increasingly precise platform for both fundamental research and therapeutic use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of cell and molecular biology-Genetics, University of science and culture, ACECR, Tehran, Iran.
- Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive BiomedicineACECR, Tehran, Iran.
- Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive BiomedicineACECR, Tehran, Iran. amir.amiriyekta@royaninstitute.org.
Zitieren
APA
Rahbari, M., Lohrasbi, R., & Amiri-Yekta, A. (2026). From scissors to editors: how the evolution of precision is redefining therapeutic genome editing. Molecular Genetics and Genomics. https://doi.org/10.1007/s00438-026-02467-3
Vancouver
Rahbari M, Lohrasbi R, Amiri-Yekta A. From scissors to editors: how the evolution of precision is redefining therapeutic genome editing. Molecular Genetics and Genomics. 2026. doi:10.1007/s00438-026-02467-3
BibTeX
@article{Rahbari2026,
author = {Rahbari, Mohadese and Lohrasbi, Reyhane and Amiri-Yekta, Amir},
title = {From scissors to editors: how the evolution of precision is redefining therapeutic genome editing},
journal = {Molecular Genetics and Genomics},
year = {2026},
doi = {10.1007/s00438-026-02467-3}
}
EUVIMED